Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease

Otology and Neurotology

Volumn 24, Issue 5, 2003, Pages 800-806

  Martin, Eduardo ^a   Perez, Nicolas ^b,c  

^a Hospital Casa de Salud Valencia   (Spain)

^b Universidad Pública de Navarra   (Spain)

^c Department of Otolaryngology ^*  (Spain)

Author keywords

Deafness; Gentamicin; Hearing loss; M ni re's Disease; Ototoxicity; Vertigo

Indexed keywords

ACETAZOLAMIDE; BETAHISTINE; GENTAMICIN; TRIMETAZIDINE;

ADULT; ARTICLE; AUDIOGRAPHY; DEAFFERENTATION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; OTOTOXICITY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VERTIGO;

AUDIOMETRY; DRUG ADMINISTRATION SCHEDULE; EAR, MIDDLE; FEMALE; FOLLOW-UP STUDIES; GENTAMICINS; HEARING LOSS, SENSORINEURAL; HUMANS; INJECTIONS; MALE; MENIERE'S DISEASE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME; VESTIBULAR FUNCTION TESTS;

EID: 0141677635     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200309000-00018     Document Type: Article

References (19)

1. Gates GA. Meniere's disease: medical therapy. In Harris JP, ed. Meniere's Disease. The Hague: Kugler Publications, 1999:329-40.
2. Fowler EP. Streptomycin treatment of vertigo. Trans Am Acad Ophthalmol Otolaryngol 1948;52:239-301.
3. Schuknecht HF. Ablation therapy in the management of Meniere's disease. Laryngoscope 1956;66:859-70.
4. Lange G. Die intratympanale Behandlung des Morbus Meniere mit ototoxischen antibiotika. Z Laryngol 1977;56:409-14.
5. Blakley BW. Update on intratympanic gentamicin for Meniere's disease. Laryngoscope 2000;110:236-40.
6. Hoffer ME, Kopke RD, Weiskopf P, et al. Use of the round window microcatheter in the treatment of Meniere's disease. Laryngoscope 2001;111:2046-9.
7. Walsted A. Unpredictable hearing loss after intratympanic gentamicin treatment of vertigo: a new theory. Acta Otolaryngol 2001;121:42-4.
8. Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol 1999;20:209-19.
9. Committee on Hearing and Equilibrium. Guidelines for diagnosing the evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
10. Perez N, Garmendia I, Martin E, Garcia-Tapia R. Adaptación cultural de dos cuestionarios de medida de la salud en pacientes con vértigo. Acta Otorrinolaring Esp 2000;51:572-80.
11. Murofushi T, Halmagyi GM, Yavor RA. Intratympanic gentamicin in Meniere's disease: results of therapy. Am J Otol 1997;18:52-7.
12. Kaasinen S, Pyykko I, Ishizaki H, Aalto H. Intratympanic gentamicin in Meniere's disease. Acta Otolaryngol 1998;118:294-8.
13. Hirsch BE, Kamerer DB. Intratympanic gentamicin therapy for Meniere's disease. Am J Otol 1997;18:44-51.
14. Atlas JT, Parnes LS. Intratympanic gentamicin titration therapy for intractable Meniere's disease. Am J Otol 1999;20:357-63.
15. Youseff TF, Poe DS. Intratympanic gentamicin injection for the treatment of Meniere's disease. Am J Otol 1998;19:435-42.
16. Harner SG, Drsicoll CL, Facer GW, Beatty CW, McDonald TJ. Long term follow-up of intratympanic gentamicin for Meniere's syndrome. Otol Neurotol 2001;22:210-4.
17. Eklund S, Pyykko I, Aalto H, Ishizaki H, Vasamat JP. Effect of intratympanic gentamicin on hearing and tinnitus in Meniere's disease. Am J Otol 1999;20:350-6.
18. Abou-Halawa AS, Poe DS. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Meniere's disease. Otol Neurotol 2002;23:494-503.
19. Forge A, Schacht J. Aminoglycoside antibiotics. Audiol Neurootol 2000;5:3-22.